Molecular responses to hypoxia in tumor cells

Molecular Cancer

Volumn 2, Issue , 2003, Pages

  Kunz, Manfred ^a   Ibrahim, Saleh M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angiogenesis; Apoptosis; Gene regulation; Hypoxia; Signal transduction

Indexed keywords

ANGIOGENIN; CYSTEINE RICH PROTEIN 61; FIBROBLAST GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR;

ANGIOGENESIS; APOPTOSIS; CELL HYPOXIA; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 1842868935     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-2-23     Document Type: Review

References (111)

1. Folkman J What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82:4-6
2. Folkman J and Shing Y Angiogenesis J Biol Chem 1992, 267:10931-10934
3. Helmlinger G, Yuan F, Dellian M and Jain RK Interstitial pH and pO2 gradients in solid tumors in vivo: High resolution measurements reveal a lack of correlation Nat Med 1997, 3:177-182
4. Harris AL Hypoxia-a key regulatory factor in tumour growth Nature Rev Cancer 2002, 2:38-47
5. Coleman CN, Mitchell JB and Camphausen K Tumor hypoxia: chicken, egg, or a piece of the farm? J Clin Oncol 2002, 20:610-615
6. Laderoute KR and Webster KA Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in rat cardiac myocytes Circ Res 1997, 80:336-344
7. Laderoute KR, Mendonca HL, Calaoagan JM, Knapp AM, Giaccia AJ and Stork PJS Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironment J Biol Chem 1999, 274:12890-12897
8. Kunz M, Ibrahim S, Koczan D, Thiesen HJ, Koehler HJ, Acker T, Plate KH, Ludwig S, Rapp UR and Broecker EB Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma Cell Growth Differ 2001, 12:137-145
9. Abbruscato TJ and Davis TP Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact Brain Res 1999, 842:277-286
10. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors Nature 1996, 379:88-91
11. Robinson MJ and Copp MH Mitogen-activated protein kinase pathways Curr Opin Cell Biol 1997, 9:180-186
12. Chang L and Karin M Mammalian MAP kinase signalling cascades Nature 2001, 410:37-40
13. Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J and Rapp UR The ins and outs of Raf kinases Trends Biochem Sci 1994, 19:474-480
14. Fanger GR, Gerwins P, Widmann C, Jarpe MB and Johnson GL MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases Curr Opin Gen Dev 1997, 7:67-74
15. Davis RJ Signal transduction by the JNK group of MAP kinases Cell 2000, 103:239-252
16. Goldberg M, Zhang HL and Steinberg SF Hypoxia alters the subcellular distribution of the protein kinase C isoforms in neonatal rat ventricular myocytes J Clin Invest 1997, 99:55-61
17. Kunz M, Bloss G, Gillitzer R, Gross G, Goebeler M, Rapp UR and Ludwig S Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways Biochem J 2002, 366:299-306
18. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T and Ichijo H ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis EMBO Rep 2001, 2:222-228
19. Karin M, Liu Z and Zandi E AP-1 function and regulation Curr Opin Cell Biol 1997, 9:240-246
20. Wojnowski L, Zimmer AM, Beck TW, Hahn H, Bernal R, Rapp UR and Zimmer A Endothelial apoptosis in Braf-deficient mice Nat Genet 1997, 16:293-297
21. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA and Simon MC Abnormal angiogenesis and response to glucose and oxygen deprivation in mice lacking the protein ARNT Nature 1997, 386:403-407
22. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ and Bottomley W Mutations of the BRAF gene in human cancer Nature 2002, 417:949-954
23. Reuther GW and Der CJ The Ras branch of small GTPases: Ras family members don't fall far from the tree Curr Opin Cell Biol 2000, 12:157-165
24. Bos JL ras oncogenes in human cancer: a review Cancer Res 1989, 49:4682-4689
25. Sheta EA, Trout H, Gildea JJ, Harding MA and Theodorescu D Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways Oncogene 2001, 20:7624-7634
26. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G and Pouyssegur J Signaling angiogenesis via p42/p44 MAP kinase and hypoxia Biochem Pharmacol 2000, 60:1171-1178
27. Clark EA, Golub TR, Lander ES and Hynes RO Genomic analysis of metastasis reveals an essential role for RhoC Nature 2000, 406:532-535
28. Semenza GL HIF-1, O(2), and the 3 PHDs. 2001. How animal cells signal hypoxia to the nucleus Cell 2001, 107:1-3
29. Wang GL and Semenza GL Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 1995, 270:1230-1237
30. Wenger RH Mammalian oxygen sensing, signalling and gene regulation J Exp Biol 2000, 203:1253-1263
31. 2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J 2002, 16:1151-1162
32. Krieg M, Haas R, Brauch H, Acker T, Flamme I and Plate KH Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function Oncogene 2000, 19:5435-5443
33. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing Science 2001, 292:464-468
34. Mahon PC, Hirota K and Semenza GL FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev 2001, 15:2675-1686
35. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML and Bruick RK FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev 2002, 16:1466-1471
36. Berra E, Pages G and Pouyssegur J MAP kinases and hypoxia in the control of VEGF expression Cancer Metastasis Rev 2000, 19:139-145
37. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth Cancer Res 2000, 60:4010-4015
38. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha Genes Dev 2000, 14:34-44
39. Kung AL, Wang S, Klco JM, Kaelin WG and Livingston DM Suppression of tumor growth through disruption of hypoxia-inducible transcription Nat Med 2000, 6:1335-1340
40. Kaelin WG Jr How oxygen makes its presence felt Genes Dev 2002, 16:1441-1445
41. Angel P and Karin M The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim Biophys Acta 1991, 1072:129-157
42. Rupec RA and Baeuerle PA The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB Eur J Biochem 1995, 234:632-640
43. Yao KS, Xanthoudakis S, Curran T and O'Dwyer PJ Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia Mol Cell Biol 1994, 14:5997-6003
44. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF and van Meir EG Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma Oncogene 1999, 18:1447-1456
45. Kunz M, Hartmann A, Flory E, Toksoy A, Koczan D, Thiesen HJ, Mukaida N, Neumann M, Rapp UR, Bröcker EB and Gillitzer R Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness Am J Pathol 1999, 155:753-763
46. Michiels C, Minet E, Michel G, Mottet D, Piret JP and Raes M HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases IUBMB Life 2001, 52:49-53
47. Koong AC, Chen EY and Giaccia AJ Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues Cancer Res 1994, 54:1425-1430
48. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P and Baeuerle PA Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. NF-κB signalling Cell 1996, 86:787-798
49. Damert A, Ikeda E and Risau W Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxiainduced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells Biochem J 1997, 327:419-423
50. Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li GC, Mendonca HL, Ryan HE, Wang Z and Johnson RS The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent Mol Cell Biol 2002, 22:2515-2523
51. Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F and Landazuri MO c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription Mol Cell Biol 2002, 22:12-22
52. Berg JM Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites Proc Natl Acad Sci U S A 1992, 89:11109-11110
53. Xu Q, Ji YS and Schmedtje JF Jr Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure J Biol Chem 2000, 275:24583-24589
54. Hanahan D and Folkman J Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996, 86:353-364
55. Carmeliet P and Jain RK Angiogenesis in cancer and other diseases Nature 2000, 407:249-257
56. Folkman J and Klagsbrun M Angiogenic factors Science 1987, 235:442-447
57. Fidler IJ and Ellis LM The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 1994, 79:185-188
58. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD and Strieter RM CXC chemokines in angiogenesis J Leukoc Biol 2000, 68:1-8
59. Rak J, Yu JL, Klement G and Kerbel RS Oncogenes and angiogenesis: signaling three-dimensional tumor growth J Investig Dermatol Symp Proc 2000, 5:24-33
60. Singh RK, Gutman M, Radinsky R, Bucana CD and Fiedler IJ Expression of interleukin-8 correlates withe metastatic potential of human melanoma cells in nude mice Cancer Res 1994, 54:3242-3247
61. Shweiki D, Itin A, Soffer D and Keshet E Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 1992, 359:843-845
62. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 1996, 16:4604-4613
63. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L and Joseph-Silverstein J Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells Proc Natl Acad Sci U S A 1995, 92:4606-4610
64. Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröcker EB and Klein CE Hypoxia-induced up-regulation of angiogenin in human malignant melanoma Cancer Res 1999, 59:1578-1583
65. Xu L, Xie K, Mukaida N, Matsushima K and Fidler IJ Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells Cancer Res 1999, 59:5822-5829
66. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT and Terris DJ Candidate genes for the hypoxic tumor phenotype Cancer Res 2000, 60:883-887
67. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ and Riggins GJ Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 2001, 93:1337-1343
68. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF and van Meir EG Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis J Exp Med 1997, 8:1201-1212
69. Skobe M, Rockwell P, Goldstein N, Vosseler S and Fusenig NE Halting angiogenesis suppresses carcinoma cell invasion Nat Med 1997, 3:1222-1227
70. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J and Connolly DT Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 1989, 246:1309-1312
71. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML and Schuh AC Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 1995, 376:62-66
72. Plate KH, Breier G, Weich HA and Risau W Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo Nature 1992, 359:845-848
73. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ and Dvorak HF Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 1996, 56:172-181
74. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF and Vallee BL Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells Biochemistry 1985, 24:5480-5486
75. Hu GF, Riordan JF and Vallee BL A putative angiogenin receptor in angiogenin-responsive human endothelial cells Proc Natl Acad Sci U S A 1997, 94:2204-2209
76. Olson KA, Fett JW, French TC, Key ME and Vallee BL Angiogenin antagonists prevent tumor growth in vivo Proc Natl Acad Sci USA 1995, 92:442-446
77. Baggiolini M, Dewald B and Moser B Human chemokines: an update Annu Rev Immunol 1997, 15:675-705
78. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG and Strieter RM Interleukin-8 as a macrophage derived mediator of angiogenesis Science 1992, 258:1798-1801
79. Mukaida N, Mahe Y and Matsushima K Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines J Biol Chem 1990, 265:21128-21133
80. O'Brien TP, Yang GP, Sanders L and Lau LF Expression of cyr61, a growth factor-inducible immediate-early gene Mol Cell Biol 1990, 10:3569-3577
81. Perbal B NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues Mol Pathol 2001, 54:57-79
82. Babic AM, Kireeva ML, Kolesnikova TV and Lau LF CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth Proc Natl Acad Sci U S A 1998, 95:6355-6360
83. Tsai MS, Hornby AE, Lakins J and Lupu R Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies Cancer Res 2000, 60:5603-5607
84. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T and Takigawa M Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line Cancer Lett 2001, 174:57-64
85. Holmgren L, O'Reilly MS and Folkman J Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1995, 1:149-153
86. Barnhill RL, Piepkorn MW, Cochran AJ, Flynn E, Karaoli T and Folkman J Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases Arch Dermatol 1998, 134:991-994
87. Saikumar P, Dong Z, Weinberg JM and Venkatachalam MA Mechanisms of cell death in hypoxia/reoxygenation injury Oncogene 1998, 17:3341-3349
88. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 1997, 91:479-489
89. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM and Venkatachalam MA Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury Oncogene 1998, 17:3401-3415
90. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H and Tsujimoto Y Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL Nature 1995, 374:811-813
91. Jacobson MD and Raff MC Programmed cell death and Bcl-2 protection in very low oxygen Nature 1995, 374:814-816
92. Bruick RK Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia Proc Natl Acad Sci U S A 2000, 97:9082-9087
93. Malhotra R, Lin Z, Vincenz C and Brosius FC 3rd Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose Am J Physiol Cell Physiol 2001, 281:C1596-C1603
94. Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM and Phillips PC Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression Oncogene 2000, 19:4604-4610
95. Shim H, Chun YS, Lewis BC and Dang CV A unique glucose-dependent apoptotic pathway induced by c-Myc Proc Natl Acad Sci U S A 1998, 95:1511-1516
96. Schmaltz C, Hardenbergh PH, Wells A and Fisher DE Regulation of proliferation-survival decisions during tumor cell hypoxia Mol Cell Biol 1998, 18:2845-2854
97. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha Nature 1998, 392:405-408
98. Suzuki H, Tomida A and Tsuruo T Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia Oncogene 2001, 20:5779-5788
99. Marte BM and Downward J PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond Trends Biochem Sci 1997, 22:355-358
100. Mayo LD and Donner DB The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network Trends Biochem Sci 2002, 27:462-467
101. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, Carrera AC, Landazuri MO and del Peso L Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis J Biol Chem 2001, 276:22368-22374
102. Bacus SS, Altomare DA, Lyass L, Chin DM, Farrell MP, Gurova K, Gudkov A and Testa JR AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival Oncogene 2002, 21:3532-3540
103. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T and Davis T Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 1997, 15:356-362
104. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH PTEN gene mutations are seen in high-grade but not in low-grade gliomas Cancer Res 1997, 57:4187-4190
105. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L and McCombie R PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 1997, 275:1943-1947
106. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC and Peacocke M Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Nat Genet 1997, 16:64-67
107. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP and Tonks NK The lipid phosphatase activity of PTEN is critical for its tumor supressor function Proc Natl Acad Sci U S A 1998, 95:13513-13518
108. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS and Jefferson AB Loss of PTEN facilitates HIF-1-mediated gene expression Genes Dev 2000, 14:391-396
109. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S and Mak TW Regulation of PTEN transcription by p53 Mol Cell 2001, 8:317-325
110. Alarcon R, Koumenis C, Geyer RK, Maki CG and Giaccia AJ Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation Cancer Res 1999, 59:6046-6051
111. Ashcroft M, Taya Y and Vousden KH Stress signals utilize multiple pathways to stabilize p53 Mol Cell Biol 2000, 20:3224-3233